Clinical Trial Update: A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis [Phase 2]

View source ↗

Summary

Phase 2 trial update showing completion of a study evaluating BAY3018250 for safety and efficacy in symptomatic proximal deep vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• BAY3018250

Snippet

Sponsor: Bayer | Conditions: Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis | Phase 2 | Status: COMPLETED